A Single & Multiple Ascending Dose Study of Subcutaneously Administered

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05881005` - NAC- NAFLD And Cushing	N/A
Recruiting	`NCT05220956` - Impact of Time-restricted Feeding in NAFLD	N/A
Enrolling by invitation	`NCT04066608` - Prevalence of Advanced Fibrosis in Patients Living With HIV
Recruiting	`NCT04302051` - Assessment of Fatty Liver With Thermo-acoustic Device
Recruiting	`NCT04496895` - The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults	N/A
Recruiting	`NCT05880316` - Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting	N/A
Active, not recruiting	`NCT05898841` - Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load	Phase 4
Not yet recruiting	`NCT06302049` - Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis	Phase 1/Phase 2
Completed	`NCT05764811` - SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity	N/A
Active, not recruiting	`NCT05076058` - Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver	N/A
Recruiting	`NCT05421572` - Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Completed	`NCT04283942` - Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism	N/A
Completed	`NCT01016418` - Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease	Phase 1/Phase 2
Terminated	`NCT04175392` - Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis	Phase 1/Phase 2
Not yet recruiting	`NCT04191044` - Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
Not yet recruiting	`NCT06071923` - Effect of Thyroid Disorders in Liver Diseases
Recruiting	`NCT04525833` - Liver Disease and Other Systemic Diseases
Not yet recruiting	`NCT05966025` - Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)	Phase 2
Completed	`NCT04367012` - Fatty Liver Among Employees at Banha University
Completed	`NCT05694923` - Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients	N/A

NCT number	NCT04844450
Study type	Interventional
Source	Janssen Research & Development, LLC
Contact
Status	Completed
Phase	Phase 1
Start date	April 29, 2021
Completion date	March 31, 2023

A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms